These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Rhamnose moiety of phosphoramidon is not required for in vivo inhibition of endothelin converting enzyme.
    Author: Pollock DM, Shiosaki K, Sullivan GM, Opgenorth TJ.
    Journal: Biochem Biophys Res Commun; 1992 Jul 31; 186(2):1146-50. PubMed ID: 1497648.
    Abstract:
    Experiments were conducted to determine the importance of the carbohydrate moiety of phosphoramidon in the inhibition of the pressor response to big endothelin-1 in anesthetized rats. Big endothelin-1 produced a 42% increase in mean arterial pressure which was nearly abolished by co-infusion of phosphoramidon. Similarly, when an analog of phosphoramidon lacking the rhamnose group (phosphoryl-leu-trp-OH) was co-infused, a significant attenuation of the pressor response was observed. These findings indicate that the rhamnose moiety of phosphoramidon is not responsible for the distinguishing this compound as an inhibitor of the response to big endothelin-1 in the rat.
    [Abstract] [Full Text] [Related] [New Search]